In a landmark event for Indian healthcare technology, Kochi-based Agappe has unveiled its first indigenously manufactured  HX series haematology equipment and the AE-powered Immunology CLIA analyser, the Mispa i200, marking a new era in diagnostics and patient care.

The HX series – HX50, HX58, HX80, and HX88 – represent the latest advancements in haematology analysers, utilising Nucleic Acid Fluorescence Staining technology. These machines, a first of their kind in India, promise to transform laboratory work by automating blood tests with unprecedented speed and accuracy. They are designed to provide comprehensive health information, aiding in the diagnosis of various conditions through blood counts, haemoglobin, platelet count, and other critical tests.

The Mispa i200, an AE-powered CLIA (Chemiluminescence Immunoassay) analyser, is a unique innovation in detecting and quantifying biomarkers such as hormones, cancer markers, cardiac markers, infectious diseases, neuro-disorders, and autoimmune markers.

Agappe's mission is to make top-tier healthcare technology accessible to all. The launch of these machines is a significant leap for Indian healthcare technology. By enhancing diagnostic capabilities and healthcare standards, these innovations are set to revolutionise patient care both in India and globally.